Pneumococcal vaccines: A dose of change. Vaccine failures and breakthrough infections in Belgian children during the PCV13 era (2019–2024)

These findings provide the first national baseline of vaccine failures, offering a reference point for evaluating PCV20 introduction. Continued monitoring will be essential to assess the real-world impact of higher-valent pneumococcal vaccines and to guide evidence-based vaccination policy.